EMJ Hematology 14 [Supplement 3] . 2026

In this issue

Expert haematologists discuss the latest updates from the myelofibrosis treatment landscape, examining new clinical data on JAK inhibitors and exploring innovative treatment approaches on the therapeutic horizon.